INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG • US46120E6023
410.85 EUR
-57.35 (-12.25%)
Last: Feb 5, 2026, 07:00 PM
Overall 1ISRG gets a fundamental rating of 7 out of 10. We evaluated 1ISRG against 65 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- 1ISRG had positive earnings in the past year.
- 1ISRG had a positive operating cash flow in the past year.
- In the past 5 years 1ISRG has always been profitable.
- In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 13.96%, 1ISRG belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 16.02%, 1ISRG belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 13.95%, 1ISRG belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
- 1ISRG had an Average Return On Invested Capital over the past 3 years of 12.43%. This is above the industry average of 9.73%.
- The last Return On Invested Capital (13.95%) for 1ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROIC | 13.95% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1.3 Margins
- 1ISRG's Profit Margin of 28.38% is amongst the best of the industry. 1ISRG outperforms 96.88% of its industry peers.
- In the last couple of years the Profit Margin of 1ISRG has grown nicely.
- With an excellent Operating Margin value of 29.35%, 1ISRG belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
- 1ISRG's Operating Margin has improved in the last couple of years.
- The Gross Margin of 1ISRG (66.00%) is better than 75.00% of its industry peers.
- In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% |
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
- Compared to 1 year ago, 1ISRG has less shares outstanding
- The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- 1ISRG has an Altman-Z score of 41.32. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
- 1ISRG's Altman-Z score of 41.32 is amongst the best of the industry. 1ISRG outperforms 98.44% of its industry peers.
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 41.32 |
ROIC/WACC1.44
WACC9.7%
2.3 Liquidity
- A Current Ratio of 4.87 indicates that 1ISRG has no problem at all paying its short term obligations.
- 1ISRG's Current ratio of 4.87 is amongst the best of the industry. 1ISRG outperforms 96.88% of its industry peers.
- 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of 1ISRG (3.96) is better than 95.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 21.83% over the past year.
- 1ISRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.42% yearly.
- The Revenue has grown by 20.51% in the past year. This is a very strong growth!
- Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 18.22% on average per year.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
3.2 Future
- Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.00% on average per year.
- The Revenue is expected to grow by 12.91% on average over the next years. This is quite good.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 54.56, 1ISRG can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
- Compared to an average S&P500 Price/Earnings ratio of 26.98, 1ISRG is valued quite expensively.
- The Price/Forward Earnings ratio is 47.68, which means the current valuation is very expensive for 1ISRG.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 68.75% of the companies listed in the same industry.
- 1ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.56 | ||
| Fwd PE | 47.68 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 65.63% of the companies in the same industry.
- 1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.49 | ||
| EV/EBITDA | 45.27 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
- 1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.59% in the coming years.
PEG (NY)3.77
PEG (5Y)2.55
EPS Next 2Y14.31%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
- 1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (2/5/2026, 7:00:00 PM)
410.85
-57.35 (-12.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.91B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target533.94 (29.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)4.89%
PT rev (3m)2.43%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.56 | ||
| Fwd PE | 47.68 | ||
| P/S | 17.2 | ||
| P/FCF | 69.49 | ||
| P/OCF | 57.11 | ||
| P/B | 9.71 | ||
| P/tB | 9.93 | ||
| EV/EBITDA | 45.27 |
EPS(TTM)7.53
EY1.83%
EPS(NY)8.62
Fwd EY2.1%
FCF(TTM)5.91
FCFY1.44%
OCF(TTM)7.19
OCFY1.75%
SpS23.89
BVpS42.31
TBVpS41.39
PEG (NY)3.77
PEG (5Y)2.55
Graham Number84.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROCE | 16.01% | ||
| ROIC | 13.95% | ||
| ROICexc | 20.73% | ||
| ROICexgc | 21.4% | ||
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% | ||
| FCFM | 24.75% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 79.72% | ||
| Cap/Sales | 5.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.46% | ||
| Profit Quality | 87.21% | ||
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 | ||
| Altman-Z | 41.32 |
F-Score8
WACC9.7%
ROIC/WACC1.44
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.56 and the Price/Book (PB) ratio is 9.71.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.